{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:03:40Z","timestamp":1790337820602,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52403173"],"award-info":[{"award-number":["52403173"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371098"],"award-info":[{"award-number":["82371098"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["CSTB2023NSCQ-MSX1077"],"award-info":[{"award-number":["CSTB2023NSCQ-MSX1077"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.mtbio.2026.103577","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T23:29:08Z","timestamp":1787182148000},"page":"103577","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Nano-drops of biomimetic macromolecular drugs based on macrophage membranes for targeted treatment of fundus diseases"],"prefix":"10.1016","volume":"40","author":[{"given":"Yongguo","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojiao","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijie","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuren","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanfu","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8055-389X","authenticated-orcid":false,"given":"Ke","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.mtbio.2026.103577_bib1","doi-asserted-by":"crossref","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","article-title":"Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis","volume":"5","author":"Flaxman","year":"2017","journal-title":"Lancet Glob Health"},{"issue":"2","key":"10.1016\/j.mtbio.2026.103577_bib2","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1016\/S2214-109X(20)30489-7","article-title":"Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the global burden of disease study","volume":"9","year":"2021","journal-title":"Lancet Glob Health"},{"issue":"2","key":"10.1016\/j.mtbio.2026.103577_bib3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jama.2023.26074","article-title":"Age-related macular degeneration: a review","volume":"331","author":"Fleckenstein","year":"2024","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103577_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41572-021-00265-2","article-title":"Age-related macular degeneration","volume":"7","author":"Fleckenstein","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.mtbio.2026.103577_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114864","article-title":"Ocular therapies with biomacromolecules: from local injection to eyedrop and emerging noninvasive delivery strategies","volume":"197","author":"Fan","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103577_bib6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1186\/s12951-024-02614-1","article-title":"Multifunctional nano-in-micro delivery systems for targeted therapy in fundus neovascularization diseases","volume":"22","author":"Liu","year":"2024","journal-title":"J Nanobiotechnology"},{"issue":"4S","key":"10.1016\/j.mtbio.2026.103577_bib7","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1016\/j.ophtha.2020.01.029","article-title":"Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: Two-Year results","volume":"127","author":"Martin","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.mtbio.2026.103577_bib8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jconrel.2023.07.055","article-title":"Challenges and strategies for ocular posterior diseases therapy via non-invasive advanced drug delivery","volume":"361","author":"Qi","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.mtbio.2026.103577_bib9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.addr.2017.09.008","article-title":"Overcoming ocular drug delivery barriers through the use of physical forces","volume":"126","author":"Huang","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103577_bib10","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3390\/gels8020082","article-title":"Drug delivery challenges and current progress in nanocarrier-based ocular therapeutic system","volume":"8","author":"Akhter","year":"2022","journal-title":"Gels"},{"key":"10.1016\/j.mtbio.2026.103577_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2023.07.028","article-title":"Selective drug delivery to the retinal cells: biological barriers and avenues","volume":"361","author":"Ramsay","year":"2023","journal-title":"J Control Release"},{"issue":"6","key":"10.1016\/j.mtbio.2026.103577_bib12","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.3390\/pharmaceutics15061646","article-title":"Corneal permeability and uptake of twenty-five drugs: species comparison and quantitative structure-permeability relationships","volume":"15","author":"Santana","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2026.103577_bib13","article-title":"Nanostructured drug delivery systems for posterior segment eye diseases: strategies to defy ocular barriers","author":"Shen","year":"2025","journal-title":"BMEMat"},{"issue":"9","key":"10.1016\/j.mtbio.2026.103577_bib14","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.ophtha.2015.05.010","article-title":"Long-term outcomes of treatment of neovascular age-related macular degeneration: data from an observational study","volume":"122","author":"Gillies","year":"2015","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.mtbio.2026.103577_bib15","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.ophtha.2020.04.017","article-title":"Retinal vasculitis and intraocular inflammation after intravitreal injection of brolucizumab","volume":"127","author":"Baumal","year":"2020","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.mtbio.2026.103577_bib16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/ICU.0000000000000850","article-title":"Complications of intravitreal injections: 2022","volume":"33","author":"Patel","year":"2022","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103577_bib17","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s13346-022-01252-0","article-title":"Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system","volume":"13","author":"Liu","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"issue":"7","key":"10.1016\/j.mtbio.2026.103577_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2024.110493","article-title":"Tumor cell membrane biomimetic liposomes-coated oncolytic viruses to target the homotypic tumor and augment the antitumor efficacy","volume":"36","author":"Wu","year":"2025","journal-title":"Chin. Chem. Lett."},{"issue":"7","key":"10.1016\/j.mtbio.2026.103577_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202301178","article-title":"Macrophage-Biomimetic nanoplatform-based therapy for inflammation-associated diseases","volume":"8","author":"Qu","year":"2024","journal-title":"Small Methods"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103577_bib20","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1186\/s12951-022-01746-6","article-title":"Macrophage cell membrane-based nanoparticles: a new promising biomimetic platform for targeted delivery and treatment","volume":"20","author":"Wu","year":"2022","journal-title":"J Nanobiotechnology"},{"issue":"15","key":"10.1016\/j.mtbio.2026.103577_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202110364","article-title":"Engineering macrophage exosome disguised biodegradable nanoplatform for enhanced sonodynamic therapy of glioblastoma","volume":"34","author":"Wu","year":"2022","journal-title":"Adv Mater"},{"issue":"8","key":"10.1016\/j.mtbio.2026.103577_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202200289","article-title":"Macrophage cell membrane-cloaked nanoplatforms for biomedical applications","volume":"6","author":"Lopes","year":"2022","journal-title":"Small Methods"},{"issue":"5","key":"10.1016\/j.mtbio.2026.103577_bib23","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1016\/j.apsb.2021.10.022","article-title":"Intravenous route to choroidal neovascularization by macrophage-disguised nanocarriers for mTOR modulation","volume":"12","author":"Xia","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.mtbio.2026.103577_bib24","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jconrel.2023.06.023","article-title":"Cell membrane-based biomimetic vehicles for effective central nervous system target delivery: insights and challenges","volume":"360","author":"Wu","year":"2023","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103577_bib25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","article-title":"A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity","volume":"17","author":"Kadry","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.mtbio.2026.103577_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jtos.2023.08.001","article-title":"Molecular nature of ocular surface barrier function, diseases that affect it, and its relevance for ocular drug delivery","volume":"30","author":"Kaur","year":"2023","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.mtbio.2026.103577_bib27","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3940241","article-title":"Ischemic retinopathies: oxidative stress and inflammation","volume":"2017","author":"Rivera","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"5","key":"10.1016\/j.mtbio.2026.103577_bib28","doi-asserted-by":"crossref","first-page":"976","DOI":"10.4103\/1673-5374.355743","article-title":"Inflammation in diabetic retinopathy: possible roles in pathogenesis and potential implications for therapy","volume":"18","author":"Tang","year":"2023","journal-title":"Neural Regen. Res."},{"issue":"21","key":"10.1016\/j.mtbio.2026.103577_bib29","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.3390\/cells11213453","article-title":"A linkage between angiogenesis and inflammation in neovascular age-related macular degeneration","volume":"11","author":"Heloter\u00e4","year":"2022","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.mtbio.2026.103577_bib30","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.survophthal.2022.07.008","article-title":"Role of inflammatory cells in pathophysiology and management of diabetic retinopathy","volume":"67","author":"Kovoor","year":"2022","journal-title":"Surv. Ophthalmol."},{"issue":"Pt 2","key":"10.1016\/j.mtbio.2026.103577_bib31","article-title":"Multifunctional macrophage membrane biomimetic nanoparticles for targeted therapy of neovascular age-related macular degeneration","volume":"388","author":"Yin","year":"2025","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103577_bib32","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1038\/s41467-020-16439-7","article-title":"Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines","volume":"11","author":"Gao","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mtbio.2026.103577_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102241","article-title":"Macrophage membrane-camouflaged biomimetic nanovesicles for targeted treatment of arthritis","volume":"95","author":"Huang","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"32","key":"10.1016\/j.mtbio.2026.103577_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202314126","article-title":"Enhanced ocular delivery of Beva via ultra-small polymeric micelles for noninvasive Anti-VEGF therapy","volume":"36","author":"Yang","year":"2024","journal-title":"Adv Mater"},{"issue":"11","key":"10.1016\/j.mtbio.2026.103577_bib35","article-title":"Peptide-Bound Aflibercept eye drops for treatment of neovascular age-related macular degeneration in Nonhuman Primates","volume":"12","author":"Fan","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"4","key":"10.1016\/j.mtbio.2026.103577_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abq3104","article-title":"Eyedrop-based macromolecular ophthalmic drug delivery for ocular fundus disease treatment","volume":"9","author":"Shen","year":"2023","journal-title":"Sci. Adv."},{"issue":"9","key":"10.1016\/j.mtbio.2026.103577_bib37","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s00018-016-2147-8","article-title":"Inflammation and its role in age-related macular degeneration","volume":"73","author":"Kauppinen","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.mtbio.2026.103577_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.100778","article-title":"Innate immune response in retinal homeostasis and inflammatory disorders","volume":"74","author":"Murakami","year":"2020","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.mtbio.2026.103577_bib39","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jconrel.2024.07.012","article-title":"Dexamethasone-loaded ROS stimuli-responsive nanogels for topical ocular therapy of corneal neovascularization","volume":"372","author":"Xiang","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.mtbio.2026.103577_bib40","article-title":"ROS-responsive drug delivery system with enhanced anti-angiogenic and anti-inflammatory properties for neovascular age-related macular degeneration therapy","volume":"32","author":"Zuo","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.mtbio.2026.103577_bib41","article-title":"ROS-responsive transmembrane peptide-antibody conjugate eyedrops for the non-invasive treatment of choroidoretinopathy","volume":"37","author":"Qu","year":"2026","journal-title":"Mater. Today Bio"}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426008227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426008227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:28:54Z","timestamp":1790335734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006426008227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":41,"alternative-id":["S2590006426008227"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103577","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nano-drops of biomimetic macromolecular drugs based on macrophage membranes for targeted treatment of fundus diseases","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103577","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103577"}}